# Sector Prediction — Healthcare — 2026-10-02

- news_mode: **on**
- ETF: **XLV**
- rubric: `00_grounding/sectors/healthcare.md`
- predicted_direction: **up**
- predicted_magnitude_band: **mild**
- total_score: **2.597** (mult 0.8)
- regime: mixed
- divergence_flagged: **False**
- engine: v2 · tape_anchor **1.506** (ES +0.50%, PM:XLV +0.23%) · index_carry **1.091** (general 4.365) · llm_overlay **0.0** (raw 0.0)

## Channel 1 sector ETF tape

```
ETF XLV vs SPY (yfinance, through 2026-10-01):
  1d: XLV -1.32% | SPY +0.18% | rel -1.50%
  3d: XLV -2.95% | SPY -0.21% | rel -2.74%
  1w: XLV -2.16% | SPY -0.42% | rel -1.74%
  1m: XLV -2.82% | SPY +0.54% | rel -3.35%
```

MEMORY_CONFIRM: Healthcare/XLV 2026-10-02. Memory index unavailable this run (embedding metadata missing — `openclaw memory index --force` if ops wants it back). Rolling HC dir=0.4 mag=0.5 (n=10); last-30 dir=0.5 mag=0.346 (n=26). Last graded **10-01 down/mild vs actual −1.318% (dir HIT, mag MISS notable)** — open experiment **applies** as keep-direction + **shrink confidence** on modest |score| (09-25/10-01 wins); 09-24 “cut conviction when sign fights tape” does **not** fire (unsigned card, live PM green). Calendar: **Fri cash session, Oct 2**; **NFP PRINTED 08:30 ET** (soft: +29k / U-rate 4.2% / AHE +0.1% MoM) — **paid this morning, not a pending binary**; **no CPI**; **FOMC+SEP+presser PRINTED 09-16** (paid, T+12); **IRA cycle-3 final offers Sep 30 = paid**; **Q3 HC mega-cap earnings not open**. **09-23 empty-spine gate FIRES** if S0–S4 net = 0 and S4 = 0 (09-25 block needs non-zero S4 **or** a factor-vs-S4 fight — neither). **09-22 emit-cap does NOT fire** (scoped to mixed/flat futures + leftover-PM down; today NQ≥ES modest green and PM:XLV **+0.23%**). **09-18 up-cap does NOT fire** (PM **+0.23% not ≤ 0**). **09-17 keep-up does NOT fire** (PM not ~+0.4% already-mild). **09-16 force-flat does NOT fire** (FOMC paid; NFP paid). **09-21 beta-arithmetic does NOT fire** (ES=F **+0.50% / NQ=F +0.68%**, not ≥+1%). **09-11 funding-source does NOT fire at full weight** (needs a *pending* binary **and** confirming rip; NFP is paid; do **not** rewrite S0 as a duration bid from same-session yield relief). **08-13 reversal-tell does NOT fire** (3d/1w/1m rel **all negative**, not leftover leadership). **09-14 destination does NOT fire** (NQ leading ES *up*). **09-10 decay cap does NOT fire** (1d rel **−1.50%**, not |rel|≤0.15%). **08-17 oil FTS narrowed off** (WTI/Brent offered off elevated levels). **08-14 policy audit: no same-morning mega-cap Rx smash** (GLOBE/MFN Part B demo *shrinks* — residual, not a re-rate; IRA paid). **08-11 MA cut stale** (April 2027 +2.48%; Sep 28 premium landscape is process). **08-21 / AMGN dazodalibep / ABT CRC test / BMY CAMZYOS / CAH–MCK CVS / CI I-Day / BSX Citi / REGN–Sanofi $8B / LLY Foundayo = single-name, nested, or T+n — must not dominate XLV**. **08-28 leftover-stack: do not copy 3d/1w/1m rel into S2/S3/S4; do not leak Thursday 1d smash −1.50% into S4 against a green PM.** Nested MAP HEAT OVERRIDE (Facilities) **not averaged into XLV**. Fear & Greed **UNAVAILABLE**. FedWatch not scrapable. size_gate=True.

# Healthcare / XLV — 2026-10-02

**Object:** near-session environment for **XLV** (not SPX, not a stock picker).

## Channel 1 (trusted, unaltered)

XLV vs SPY through **2026-10-01**: **1d −1.32% / +0.18% (rel −1.50%)**; 3d rel **−2.74%**; 1w rel **−1.74%**; 1m rel **−3.35%**. Thursday was a **hard underperformance on a mildly green SPY tape** — the −1.50% 1d rel is a *paid* smash, not today’s confirmation. **All four relative horizons are red.** 1m is a **deep relative lag** — crowded-long fuel is gone. 08-13 leftover-RS leadership is **absent**.

Macro: VIX **15.95** (−0.44 1d, +1.08 1w); **VIX/VIX3M 0.858 contango**. **Finviz futures: ES +0.20%, NQ +0.41%, RTY +0.08%, DJIA +0.11%** — modest green, **NQ leading**. Separate **`[ES=F +0.50%] / [NQ=F +0.68%]`** — both panels agree on sign and on NQ≥ES; both agree this is **not** a ≥+1% rip. **WTI −1.59% / Brent −1.02% / CL=F −3.97% / BZ=F −2.48%** — oil **offered**. **DGS10 5.29** (as-of 09-30: +0.03 1d, +0.18 1w, **+0.54 1m**) / **DFII10 2.93** (+0.02 1d, +0.17 1w, **+0.49 1m**) — real yields **still up on the week/month**. DXY **−0.09% 1d, +2.46% 1m**. HY OAS **3.12** (+0.39 1w). Asia composite **−0.40%** (Hang Seng −2.6%); Europe **+0.79%**. **PM: XLV +0.23% vs XLK +0.78%, XLI +0.62%, XLP +0.60%, XLY +0.39%, XLF +0.25%, XLU −0.09%, XLE −0.99%** — healthcare is **modestly green, not worst-on-board, not a haven** (staples outrun it). **FOMC paid. NFP paid. size_gate=True.**

## Channel 2

**1. Shared macro → this sector (S0).** Pre-open tape is a **modest, NQ-led risk-on** with oil offered and VIX contango — a *weak* 09-11 funding-source *shape*, not a regime day. Soft NFP (+29k / 4.2% / wages +0.1%) is a **same-session rates-relief print**, not a recession-haven bid: ES/NQ stay green, XLP is the defensive sleeve that actually leads, XLV **lags XLK**. 09-11 inversion still binds: **do not rewrite S0 as a duration bid from the NFP yield dip**, and do not restack DFII10’s 1m +0.49 into a second XBI shock (09-10). 09-21 beta-arithmetic is **off** (not ≥+1%). 09-14 destination is **off** (NQ leading *up*). 09-18 up-cap is **off** (PM +0.23% > 0). 09-17 keep-up is **off** (not already ~+0.4%). Live PM green **forbids converting Thursday’s smash into a signed down**. **S0 = 0**. Do not score oil-falling as “rotation into healthcare.” Do not map XLK/NQ into S0=+1.

**2. Spine / secondary (S1).**
- **CMS / MA 2027 +2.48%:** April finalization — **stale**. Sep 28 premium/landscape stability is process. **Checked, nothing material.**
- **Biotech / XBI:** MAP HEAT Biotechnology **dir=flat** (REGN pos on Sanofi immunology expansion; VRTX quiet). XBI PM bounce after Thursday −2% is **not leadership**. FDA FY2026 funding lapse stalling **new user-fee submissions** is XBI/small-cap process risk, **not an XLV spine**. Not a funding-winter cluster. Do not promote the XBI sleeve (09-11/09-17).
- **Drug pricing:** IRA cycle-3 **paid Sep 30**. Axios **2026-10-02** GLOBE/MFN Part B demo **shrinks** (~$440M/5yr) — mild residual *relief*, not a mega-cap re-rate. MFN 50-state Medicaid is **09-18 residual**. **No same-morning Rx smash.** 08-14 does **not** fire.
- **Utilization / insurers:** commercial trend still elevated (UNH commentary residual); MAP HEAT Plans **up / medium** is **nested residual**, not a same-morning MA-rate HIT. **Checked, nothing material** as a live utilization-spike HIT.
- **FDA / trials:** ABT SimpleScreen CRC, BMY CAMZYOS expansion, AMGN dazodalibep (T+n), LLY Foundayo = **single-name**. No approval/CRL *cluster*.
- **Rotation:** Thursday was rotation **out**; live PM is a **tag-along**, not a fresh out or in HIT.

**S1 = 0.** Nested HEAT must not invent a parent spine.

**3. Breadth (S2).** Nested Plans / Facilities OVERRIDE / Distribution / Dx / HIS print **residual up vs XLV** at **low–medium conv** with mostly silent captains. Biotech, devices, big pharma **flat**. Parent PM **+0.23%** is participation, not ETF-only carry and not expansion. 10-01 “don’t zero S2 against a worst-on-board parent” is **off** — XLV is **not** worst-on-board today. Do **not** copy Thursday −1.50% rel into S2 (08-28). **S2 = 0.**

**4. Flows / positioning (S3).** XLV 5d creations ~+$238M / Oct 1 ~$136.5M across all 60 names; 1m flows mildly negative; 1y still positive. XBI has **recent redemptions**. 1m rel **−3.35%** is the **opposite of a crowded long**. Not a volume-spike chase and not forced index selling. **S3 = 0.**

**5. ETF tape (S4) — confirmation only.** Channel 1 1d/3d/1w/1m rel are all red, but that 1d **already printed** and live PM is **green**. Putting S4 < 0 would make leftover tape the *only* signed factor — the 09-22 leak. S4 > 0 would invent a bounce the relative book does not show. **S4 = 0.**

**Catalysts:** NFP is **paid**. No HC mega-cap earnings. No live CMS-rate or IRA HIT. Single-name FDA/BD stays nested.

## Self-audit

- **Lens:** XLV environment, not SPX, not LLY/AMGN/UNH.
- **Band:** unsigned card + size_gate → **flat**, not notable.
- **Skew:** leftover 1m lag is **not** a down mandate; green PM is **not** 09-17 keep-up.
- **Same-shock:** oil-offered counted once (not again as HC rotation); NFP yield dip **not** restacked into S0 and S1.
- **Single-ticker:** AMGN/ABT/BMY/REGN/CAH/CI/BSX **out**.
- **Divergence:** leading S0–S4 sum **= 0** and S4 **= 0** — no factor-vs-tape fight. If the engine still mints a signed call off `index_carry` / ES tape_anchor, **trust this factor card (flat)** (09-23). 09-25’s “defer to engine” block needs non-zero S4 or a real S4 fight — **not today**.
- **Beta check:** SPY/ES ~+0.5% × XLV beta ~0.65 ≈ **+0.3%** gross — **flat band**, not mild-up from carry.

**REGIME:** mixed. **MULTIPLIER 0.8** (size_gate). **CONFIDENCE 0.42** (shrink on |score|≈0; HC 40% last 15).

SECTOR_SCORES_BEGIN
S0_SHARED_MACRO: 0
S1_SECTOR_FACTORS: 0
S2_BREADTH: 0
S3_FLOWS_POSITIONING: 0
S4_ETF_TAPE: 0
MULTIPLIER: 0.8
CONFIDENCE: 0.42
REGIME: mixed
HORIZON_3D: 0
HORIZON_1W: -0.5
HORIZON_2W: -0.5
HORIZON_1M: -1
SECTOR_SCORES_END

HIT_GRID_BEGIN
Risk-on tape / equity beta expansion|WATCH|0.55|2026-10-02|https://www.reuters.com/business/wall-st-futures-gain-yields-oil-prices-ease-ahead-jobs-report-2026-10-02/
Risk-off tape / flight to safety|NONE|0.70|2026-10-02|
Real yields rising|WATCH|0.60|2026-09-30|https://fred.stlouisfed.org/series/DFII10
Real yields falling|NONE|0.55|2026-10-02|https://www.cnbc.com/2026/10/02/treasury-yields-bonds-nonfarm-payrolls.html
USD strengthening|NONE|0.50|2026-10-02|
USD weakening|NONE|0.45|2026-10-02|
Sector breadth expansion (% names up)|NONE|0.55|2026-10-02|
Sector breadth failure (ETF up, names flat)|NONE|0.50|2026-10-02|
Large-cap leadership inside sector|WATCH|0.45|2026-10-02|
Small/mid leadership inside sector|NONE|0.50|2026-10-02|
High-beta leadership inside sector|NONE|0.55|2026-10-02|
Low-beta leadership inside sector|NONE|0.50|2026-10-02|
Sector ETF inflow / relative volume spike|WATCH|0.50|2026-10-01|https://etfdb.com/etf/XLV/
Sector ETF outflow / volume dry-up|NONE|0.50|2026-10-02|
Crowded long (extreme relative performance + valuation)|NONE|0.70|2026-10-01|
Index rebalance / inclusion tailwind|NONE|0.40|2026-10-02|
Index exclusion / forced selling|NONE|0.40|2026-10-02|
FDA approval / favorable panel (sector breadth)|NONE|0.65|2026-10-02|
Positive late-stage trial readout (breadth)|NONE|0.60|2026-10-02|
CMS / Medicare Advantage rate upside|NONE|0.75|2026-04-06|https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-rate-announcement
Biotech risk-on / XBI leadership|NONE|0.60|2026-10-02|
Drug pricing policy relief|WATCH|0.45|2026-10-02|https://www.axios.com/2026/10/02/medicare-drug-price-experiment-shrinks
FDA rejection / CRL / trial failure (breadth)|NONE|0.55|2026-10-02|
Medicare rate cut / reimbursement pressure|NONE|0.70|2026-04-06|https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-rate-announcement
Drug pricing crackdown / IRA expansion risk|NONE|0.60|2026-09-30|
Biotech risk-off / funding winter|WATCH|0.40|2026-10-01|https://www.bioworld.com/articles/724640-new-fda-submissions-stalled-during-us-government-funding-lapse
Utilization spike hurting insurers|NONE|0.50|2026-10-02|
Sector rotation into healthcare|NONE|0.60|2026-10-02|
Sector rotation out of healthcare|WATCH|0.50|2026-10-01|
HIT_GRID_END

---

## RESEARCH APPENDIX

**Queries run**
- memory_search: Healthcare XLV sector prediction lessons CMS IRA XBI drug pricing (index unavailable)
- web_search: XLV healthcare ETF premarket October 2 2026 XBI relative performance flows
- web_search: CMS Medicare Advantage 2027 rates IRA drug pricing October 2026
- web_search: NFP payrolls October 2 2026 release time healthcare stocks reaction
- web_search: biotech XBI risk on funding FDA approvals October 2026
- web_search: US nonfarm payrolls September 2026 actual result October 2
- web_search: XBI XLV October 2 2026 premarket breadth UNH LLY JNJ AMGN
- web_search: healthcare ETF flows XLV IHI XBI October 2026 crowding
- web_search: drug pricing IRA MFN healthcare policy October 2 2026
- web_search: FDA government shutdown October 2026 new submissions stalled
- web_search: 10 year yield after NFP October 2 2026 ES futures healthcare
- web_search: healthcare utilization insurers UNH HUM medical cost trend October 2026
- web_search: healthcare M&A October 2026 biotech deals XLV
- x_search: XLV XBI healthcare stocks NFP payrolls October 2 2026 premarket reaction (2026-10-01..2026-10-02)
- web_fetch: https://www.bls.gov/news.release/empsit.nr0.htm (403)
- web_fetch: https://www.axios.com/2026/10/02/medicare-drug-price-experiment-shrinks (403)

**Key sources and facts used**
- BLS Employment Situation via search summary — https://www.bls.gov/news.release/empsit.nr0.htm — 2026-10-02: NFP **+29k**, U-rate **4.2%**, AHE **+0.1% MoM / +3.0% YoY** (below ~80–94k consensus).
- CNBC / Reuters futures-yields — https://www.cnbc.com/2026/10/02/treasury-yields-bonds-nonfarm-payrolls.html ; https://www.reuters.com/business/wall-st-futures-gain-yields-oil-prices-ease-ahead-jobs-report-2026-10-02/ — 10Y eased modestly off week highs; ES/NQ green into/around the print.
- CMS CY2027 MA Rate Announcement — https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-rate-announcement — **+2.48%** net MA payment increase, finalized **April 6, 2026** (stale for today).
- CMS MA/Part D 2027 premium landscape — https://www.cms.gov/newsroom/press-releases/medicare-advantage-medicare-prescription-drug-programs-expected-remain-stable-2027 — Sep 28 process/stability, not a same-morning rate HIT.
- Axios GLOBE/MFN Part B demo shrink — https://www.axios.com/2026/10/02/medicare-drug-price-experiment-shrinks — 2026-10-02: demo narrowed, savings ~$440M/5yr (mild residual relief, not an XLV re-rate).
- BioWorld / PharmExec FDA lapse — https://www.bioworld.com/articles/724640-new-fda-submissions-stalled-during-us-government-funding-lapse — Oct 1 funding lapse: **new user-fee submissions stalled** (XBI-relevant, not XLV spine).
- ETFDB / GuruFocus XLV flows — https://etfdb.com/etf/XLV/ ; https://www.gurufocus.com/news/9105180/state-street-health-care-spdr-xlv-adds-eli-lilly-and-jnj-on-tuesday — 5d ~+$238M; Oct 1 ~$136.5M creations (LLY/JNJ/ABBV).
- MarketWatch / Tradesmith XBI/XLV PM — XBI bounce after Thu **−2.01%**; XLV PM ~**+0.3%** after Thu **−1.32%** (Channel 1 PM **+0.23%** trusted over these).
- MAP HEAT (injected) — Biotech **flat**; Plans/Distribution residual **up**; Facilities **OVERRIDE** not averaged into XLV.
- Channel 1 panel (injected, unaltered) — XLV/SPY 1d/3d/1w/1m rel; ES=F **+0.50%**, NQ=F **+0.68%**; PM board; DGS10 **5.29**, DFII10 **2.93**; VIX **15.95**.

---
## Pipeline-computed decision (deterministic)

```json
{'components': {'S0_SHARED_MACRO': 0.0, 'S1_SECTOR_FACTORS': 0.0, 'S2_BREADTH': 0.0, 'S3_FLOWS_POSITIONING': 0.0, 'S4_ETF_TAPE': 0.0}, 'multiplier': 0.8, 'leading_sum': 0.0, 'divergence_flagged': False, 'total_score': 2.597, 'predicted_direction': 'up', 'predicted_magnitude_band': 'mild', 'confidence_score': 0.604, 'regime': 'mixed', 'engine': 'v2', 'anchor': {'available': True, 'pct': 0.251, 'score': 1.506, 'legs': [{'leg': 'ES', 'pct': 0.5, 'w': 0.6}, {'leg': 'PM:XLV', 'pct': 0.23, 'w': 0.7}]}, 'overlay_score': 0.0, 'overlay_raw': 0.0, 'index_carry': 1.091, 'general_total': 4.365, 'skill_multipliers': {'S0_SHARED_MACRO': 0.0, 'S1_SECTOR_FACTORS': 1.25, 'S2_BREADTH': 1.25, 'S3_FLOWS_POSITIONING': 1.25, 'S4_ETF_TAPE': 1.25}, 'llm_confidence': 0.42, 'calendar_size_gate_applied': True, 'calendar_size_gate_reason': 'set by pre-open refresh'}
```
